Bioengine Capital Inc. is > 10% Shareholder of WINDTREE THERAPEUTICS INC . Currently has a direct ownership of 0 shares of WINT, which is worth approximately $0. The most recent transaction as insider was on Dec 30, 2021, when has been sold 1,239,088 shares (Common Stock) at a price of $1.6 per share, resulting in proceeds of $1,982,541. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Bioengine Capital Inc. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 30 2021
SELL
Open market or private sale
$1,982,541 $1.6 p/Share
1,239,088 Reduced 100.0%
0 Common Stock
May 20 2020
SELL
Other acquisition or disposition
-
3,551,750 Reduced 75.0%
1,183,916 Common Stock
May 20 2020
BUY
Open market or private purchase
$399,997 $7.25 p/Share
55,172 Added 4.26%
1,239,088 Common Stock
BCI

Bioengine Capital Inc.

> 10% Shareholder
Taipei City, F5

Track Institutional and Insider Activities on WINT

Follow WINDTREE THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells WINT shares.

Notify only if

Insider Trading

Get notified when an Windtree Therapeutics Inc insider buys or sells WINT shares.

Notify only if

News

Receive news related to WINDTREE THERAPEUTICS INC

Track Activities on WINT